JP2018533941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018533941A5 JP2018533941A5 JP2018520100A JP2018520100A JP2018533941A5 JP 2018533941 A5 JP2018533941 A5 JP 2018533941A5 JP 2018520100 A JP2018520100 A JP 2018520100A JP 2018520100 A JP2018520100 A JP 2018520100A JP 2018533941 A5 JP2018533941 A5 JP 2018533941A5
- Authority
- JP
- Japan
- Prior art keywords
- copper
- vector
- nucleic acid
- composition
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562244594P | 2015-10-21 | 2015-10-21 | |
| US62/244,594 | 2015-10-21 | ||
| PCT/US2016/058124 WO2017070472A1 (en) | 2015-10-21 | 2016-10-21 | Codon-optimized reduced-size atp7a cdna and uses for treatment of copper transport disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020218556A Division JP2021052796A (ja) | 2015-10-21 | 2020-12-28 | コドン最適化された小型ＡＴＰ７Ａ ｃＤＮＡおよび銅輸送障害を処置するための使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018533941A JP2018533941A (ja) | 2018-11-22 |
| JP2018533941A5 true JP2018533941A5 (https=) | 2019-11-28 |
| JP6854286B2 JP6854286B2 (ja) | 2021-04-07 |
Family
ID=57256420
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018520100A Active JP6854286B2 (ja) | 2015-10-21 | 2016-10-21 | コドン最適化された小型ＡＴＰ７Ａ ｃＤＮＡおよび銅輸送障害を処置するための使用 |
| JP2020218556A Pending JP2021052796A (ja) | 2015-10-21 | 2020-12-28 | コドン最適化された小型ＡＴＰ７Ａ ｃＤＮＡおよび銅輸送障害を処置するための使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020218556A Pending JP2021052796A (ja) | 2015-10-21 | 2020-12-28 | コドン最適化された小型ＡＴＰ７Ａ ｃＤＮＡおよび銅輸送障害を処置するための使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US10988778B2 (https=) |
| EP (1) | EP3365438B1 (https=) |
| JP (2) | JP6854286B2 (https=) |
| CN (1) | CN108431216B (https=) |
| AU (1) | AU2016341983B8 (https=) |
| DK (1) | DK3365438T3 (https=) |
| ES (1) | ES2879400T3 (https=) |
| HU (1) | HUE054802T2 (https=) |
| PL (1) | PL3365438T3 (https=) |
| PT (1) | PT3365438T (https=) |
| WO (1) | WO2017070472A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210290571A1 (en) * | 2018-07-12 | 2021-09-23 | The Texas A&M University System | Compositions for the treatment of copper deficiency and methods of use |
| US20240139236A1 (en) * | 2021-03-18 | 2024-05-02 | Cyprium Therapeutics, Inc. | Copper histidinate compositions and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993017321A1 (en) | 1992-02-25 | 1993-09-02 | Unisearch Limited | Electrothermal atomic absorption and preconcentration device |
| EP0606516B1 (en) | 1993-01-13 | 1998-12-30 | Idemitsu Kosan Company Limited | Anti-human ceruloplasmin monoclonal antibody |
| US6759050B1 (en) | 1998-12-03 | 2004-07-06 | Avigen, Inc. | Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| KR100459644B1 (ko) | 2001-03-31 | 2004-12-03 | 제노백(주) | 혈액 여과지에서의 효소면역측정법을 이용한셀룰로플라스민 농도 측정 방법 및 이 방법을 이용한윌슨병 스크리닝 검사용 키트와 진단 시약 |
| US7261544B2 (en) | 2003-05-21 | 2007-08-28 | Genzyme Corporation | Methods for producing preparations of recombinant AAV virions substantially free of empty capsids |
| US20070161120A1 (en) | 2006-01-10 | 2007-07-12 | Viorica Lopez-Avila | Ceruloplasmin Assay |
| US8101727B2 (en) * | 2006-03-30 | 2012-01-24 | Novartis Ag | Compositions and methods of use for antibodies of c-Met |
| EP2058401A1 (en) * | 2007-10-05 | 2009-05-13 | Genethon | Widespread gene delivery to motor neurons using peripheral injection of AAV vectors |
| ES2751999T3 (es) | 2008-01-29 | 2020-04-02 | Applied Genetic Tech Corporation | Producción recombinante de virus adeno-asociados usando células BHK en suspensión |
| WO2010042102A1 (en) | 2008-10-06 | 2010-04-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Identification of subjects likely to benefit from copper treatment |
| WO2010071832A1 (en) * | 2008-12-19 | 2010-06-24 | Nationwide Children's Hospital | Delivery of polynucleotides across the blood brain barrier using recombinant aav9 |
| US9415121B2 (en) | 2008-12-19 | 2016-08-16 | Nationwide Children's Hospital | Delivery of MECP2 polynucleotide using recombinant AAV9 |
| WO2010114948A2 (en) | 2009-04-02 | 2010-10-07 | University Of Florida Research Foundation, Inc. | An inducible system for highly efficient production of recombinant adeno-associated virus (raav) vectors |
| MX367100B (es) * | 2012-02-17 | 2019-08-05 | The Children´S Hospital Of Philadelphia | Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos. |
| WO2013151665A2 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins associated with human disease |
| CN104411338A (zh) * | 2012-04-02 | 2015-03-11 | 现代治疗公司 | 用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸 |
-
2016
- 2016-10-21 ES ES16794111T patent/ES2879400T3/es active Active
- 2016-10-21 WO PCT/US2016/058124 patent/WO2017070472A1/en not_active Ceased
- 2016-10-21 CN CN201680074686.6A patent/CN108431216B/zh active Active
- 2016-10-21 HU HUE16794111A patent/HUE054802T2/hu unknown
- 2016-10-21 US US15/769,294 patent/US10988778B2/en active Active
- 2016-10-21 DK DK16794111.1T patent/DK3365438T3/da active
- 2016-10-21 AU AU2016341983A patent/AU2016341983B8/en active Active
- 2016-10-21 JP JP2018520100A patent/JP6854286B2/ja active Active
- 2016-10-21 PL PL16794111T patent/PL3365438T3/pl unknown
- 2016-10-21 PT PT167941111T patent/PT3365438T/pt unknown
- 2016-10-21 EP EP16794111.1A patent/EP3365438B1/en active Active
-
2020
- 2020-12-28 JP JP2020218556A patent/JP2021052796A/ja active Pending
-
2021
- 2021-03-30 US US17/217,961 patent/US12173306B2/en active Active
-
2024
- 2024-12-16 US US18/982,427 patent/US20250129382A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Streicher | Exploring the future of infectious disease treatment in a post-antibiotic era: A comparative review of alternative therapeutics | |
| JP2019194251A5 (https=) | ||
| JP2016538885A5 (https=) | ||
| JP2018501791A5 (https=) | ||
| JP2023144087A5 (https=) | ||
| Wallach et al. | Advances in the treatment of neuromyelitis optica spectrum disorder | |
| JP2017538395A5 (https=) | ||
| JP2018503361A5 (https=) | ||
| JP2019513779A5 (https=) | ||
| JP2015518818A5 (https=) | ||
| Journeycake | Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics | |
| US10028998B2 (en) | Method for treating an inflammatory disease and/or an autoimmune disease with a soluble FcγRIIb | |
| JP2016516073A5 (https=) | ||
| JP2013523718A5 (https=) | ||
| EP3735421A1 (en) | Methods for treating il-6 mediated inflammation without immunosuppression | |
| AU2020203410A1 (en) | Novel peptides and analogs for use in the treatment of oral mucositis | |
| JP2019531293A5 (https=) | ||
| FELDMEyER et al. | Not all intravenous immunoglobulin preparations are equally well tolerated | |
| JP2018533941A5 (https=) | ||
| JP2015514115A5 (https=) | ||
| JP2021511043A5 (https=) | ||
| IL308645B1 (en) | Viral vectors comprising RDH12 coding regions and methods for treating retinal dystrophies | |
| US10953078B2 (en) | Treatment and/or prevention of sepsis | |
| Cela et al. | Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE) | |
| JP2019501925A5 (https=) |